Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - REVENUE
Revenue FOLD - Amicus Therapeutics, Inc.
399 M
LAST VALUE
14.33%
2 YEAR CAGR
34.35%
5 YEAR CAGR
101.44%
10 YEAR CAGR